Triplett Michael W
Known title: President, U.S. CommercialCIK: 0001698840
Associated companies
Transaction History
| CI | ▼ Sell | Open Market | 5,034 | $1.7M | 8/12/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 7,200 | $1.1M | 8/12/2024 | View on chart |
| CI | ▼ Sell | Open Market | 1,785 | $591K | 8/12/2024 | View on chart |
| CI | ▼ Sell | Open Market | 1,953 | $650K | 3/4/2024 | View on chart |
| CI | ▲ Buy | Grant | 5,702 | $0 | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 749 | $250K | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 2,492 | $831K | 3/1/2024 | View on chart |
| CI | ▲ Buy | Grant | 1,709 | $0 | 2/28/2024 | View on chart |
| CI | ▼ Sell | Open Market | 1,731 | $470K | 3/10/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 805 | $233K | 3/1/2023 | View on chart |
| CI | ▲ Buy | Grant | 5,633 | $0 | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 280 | $82K | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 2,172 | $639K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 2,050 | $0 | 2/22/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,449 | $341K | 9/13/2022 | View on chart |
| CI | ▲ Buy | Option Exercise | 6,060 | $844K | 9/12/2022 | View on chart |
| CI | ▼ Sell | Open Market | 8,260 | $2.4M | 9/12/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 405 | $96K | 3/1/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 805 | $185K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,641 | $0 | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 539 | $124K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,660 | $0 | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.